These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33185911)

  • 1. Neutral Ceramidase Mediates Nonalcoholic Steatohepatitis by Regulating Monounsaturated Fatty Acids and Gut IgA
    Gu X; Sun R; Chen L; Chu S; Doll MA; Li X; Feng W; Siskind L; McClain CJ; Deng Z
    Hepatology; 2021 Mar; 73(3):901-919. PubMed ID: 33185911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma.
    Ducheix S; Piccinin E; Peres C; Garcia-Irigoyen O; Bertrand-Michel J; Fouache A; Cariello M; Lobaccaro JM; Guillou H; Sabbà C; Ntambi JM; Moschetta A
    Hepatol Commun; 2022 Oct; 6(10):2937-2949. PubMed ID: 35903850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
    Snider AJ; Wu BX; Jenkins RW; Sticca JA; Kawamori T; Hannun YA; Obeid LM
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):124-30. PubMed ID: 22940715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.
    Sun R; Gu X; Lei C; Chen L; Chu S; Xu G; Doll MA; Tan Y; Feng W; Siskind L; McClain CJ; Deng Z
    Cell Rep; 2022 Mar; 38(13):110560. PubMed ID: 35354041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
    Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M
    J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions of neutral ceramidase in the Golgi apparatus.
    Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
    J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
    Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
    Li ZZ; Berk M; McIntyre TM; Feldstein AE
    J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
    Rubio C; Puerto M; García-Rodríquez JJ; Lu VB; García-Martínez I; Alén R; Sanmartín-Salinas P; Toledo-Lobo MV; Saiz J; Ruperez J; Barbas C; Menchén L; Gribble FM; Reimann F; Guijarro LG; Carrascosa JM; Valverde ÁM
    Mol Metab; 2020 May; 35():100954. PubMed ID: 32244182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-Inactivated
    Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Coant N; García-Barros M; Zhang Q; Obeid LM; Hannun YA
    Oncogene; 2018 Jul; 37(28):3852-3863. PubMed ID: 29662189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neutral ceramidase in colon cancer.
    García-Barros M; Coant N; Kawamori T; Wada M; Snider AJ; Truman JP; Wu BX; Furuya H; Clarke CJ; Bialkowska AB; Ghaleb A; Yang VW; Obeid LM; Hannun YA
    FASEB J; 2016 Dec; 30(12):4159-4171. PubMed ID: 27609772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.
    Novgorodov SA; Wu BX; Gudz TI; Bielawski J; Ovchinnikova TV; Hannun YA; Obeid LM
    J Biol Chem; 2011 Jul; 286(28):25352-62. PubMed ID: 21613224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.